The Food and Drug Administration (FDA) has nominated “narcolepsy” for a groundbreaking new patient-focused drug development initiative. Only 20 diseases will be chosen. Please join me in urging the FDA to select “narcolepsy” for this important effort.
About the FDA Initiative:
“Narcolepsy” is one of 39 disease areas nominated for a new FDA initiative to better inform the FDA’s drug and biologics review process with input from patients who experience particular diseases or conditions. (Details here)
Only 20 disease areas will be chosen.Two weeks ago, I attended the preliminary planning meeting at the FDA and this Thursday, I will attend the packed in-person meeting to urge FDA to choose narcolepsy.
I need your voices behind me, sent in via public comments.
Your Voice Counts:
• The FDA is soliciting Public Comments to help choose the final 20.
• People with narcolepsy, loved ones and caregivers are ALL encouraged to comment.
• You can comment anonymously or using your name.
• Act now! The Nov. 1st deadline is quickly approaching.
Working with public policy experts, I’ve created this Submission Guide and Example Letter for the narcolepsy community.
The more comments, the greater our chances. Please take two minutes today to build a brighter future for narcolepsy tomorrow.
For updated posts about the FDA Initiative, click here.